Kositsawat, Jatupol
Vogrin, Sara
French, Chloe
Gebauer, Maria
Candow, Darren G.
Duque, Gustavo
Kirk, Ben http://orcid.org/0000-0002-0176-776X
Funding for this research was provided by:
University of Melbourne
Article History
Received: 29 June 2022
Accepted: 26 October 2022
First Online: 7 November 2022
Declarations
:
: GD serves as a member of the Advisory Board for Abbott Australia and TSI Pharmaceuticals both of which manufacture/sell nutritional products. BK has received speaker fees from Abbott UK (over 36 months ago) and is currently supported by a research fellowship from TSI Pharmaceuticals. DGC serves on the Scientific Advisory Board for Alzchem, a company that manufactures a nutritional product called creatine. GD, BK and DC declare they have no direct conflicts of interest in relation to the current study. JK, SV, CF and MG have no conflicts of interest to declare.
: Ethical approval for NHANES (1999–2004) was received from the NCHS Research Ethics Review Board (ERB): Protocol #98–12. All study procedures followed the ethical standards outlined by the NCHS Research ERB for human participants and were in line with the Declaration of Helsinki.
: All participants provided written informed consent in accordance with the Centers for Disease Control and Prevention (CDC).